Experimental Cancer Drug Metarrestin Targets Metastatic Tumors

Researchers have struggled to develop therapies to treat tumors that have spread to other parts of the body. In a new study, researchers tested whether the experimental drug metarrestin can selectively shrink metastases in mouse models of aggressive pancreatic cancer.

Cancer Currents: An NCI Cancer Research Blog